Fairvalue-Calculator Fairvalue-Calculator
EN DE

SpineGuard SA (ALSGD) Fair Value & Analysis

Healthcare · FR · Market cap €9.0M

Price€0.0842
Fair Value€0.0217
Upside-74.2%
Quality95/100
Evidence: Low

Fair value as of: Jun 26, 2026

✦ Find undervalued quality stocks — 34,000+ analysed Find stocks →

Analysis

SpineGuard SA (ALSGD) currently trades at €0.0842, while our model-based Fair Value estimate is €0.0217 — implying the stock looks roughly 74.2% overvalued today. We read business quality at 95/100 (high quality), in the Healthcare sector. Bear case: priced above our estimate, the market already discounts strong expectations. Bull case: above-average quality can justify a premium — the entry price still matters most (evidence: low).

About the company

SpineGuard SA provides designs, develops, and markets medical devices for spine in France and internationally. The company offers PediGuard drilling instruments comprising straight, curved, cannulated, psifguard, and threaded PediGuard products; and DSG smart screw that allows for one step screw placement treatment. It also provides DSG (Dynamic Surgical Guidance) Connect app that allows collection and visualization of the signal measured at the tip of DSG Connect devices during pedicle drilling, as well as DSG for orthopedic robots and dental implantology products. SpineGuard SA was incorporated in 2009 and is headquartered in Vincennes, France.

Open the full interactive analysis →

Similar stocks

Frequently asked questions

Is SpineGuard SA (ALSGD) undervalued?
As of Jun 26, 2026, our model estimates a fair value of €0.0217 versus a price of €0.0842 — about −74% (overvalued). Model-based estimate, not financial advice.
What is the fair value of ALSGD?
Our 21-model fair value for SpineGuard SA is €0.0217 (as of Jun 26, 2026), built from audited fundamentals. The current price is €0.0842.
What is the quality score of ALSGD?
SpineGuard SA has a Quality Score of 95/100, measuring profitability, growth and balance-sheet strength from non-valuation factors.

How we calculate Fair Value

Each company is valued through a stack of independent intrinsic-value models (DCF variants, residual-income, multiples and more), blended into one family-balanced consensus and weighted by how much trustworthy data backs it. A separate quality layer scores the fundamentals. Every input is real reported data — nothing guessed.

Educational research only · not financial advice · no buy/sell recommendation. Model-based estimates are not certainties; their reliability depends on data quality and assumptions.